Psychedelic Medicine


Psychedelic Drug-Drug Interactions

Log In To Watch the Recording

*Exclusive for members.

Thursday, February 23rd at 5 pm Pacific, 8 pm Eastern >> Log in to Watch the Recording >>

Watch The EXCLUSIVE Panel Discussion For Members Of The Psychedelic Medicine Association:

Psychedelic Drug-Drug Interactions

Panel Moderator:

Lynn Marie Morski, MD, JD

President - Psychedelic Medicine Association


Benjamin Malcolm, PharmD, MPH, BCPP will present at Psychedelic Medicine Association February 2023 member's only webinar on psychedelic drug-drug interactions

Benjamin Malcolm, PharmD, MPH, BCPP

Founder, Spirit Pharmacist LLC

Dr. Ben Malcolm earned his bachelor’s degree (BS) in pharmacology at the University of California at Santa Barbara, prior to his Masters in Public Health (MPH) and Doctorate of Pharmacy (PharmD) at Touro University California. He then completed post-graduate residencies in Acute Care at Scripps Mercy Hospital and Psychiatric Pharmacy at the University of California at San Diego Health. 

After residency he passed his exam to become Board Certified in Psychiatric Pharmacy (BCPP). He began his career as an Assistant Clinical Professor at Western University of Health Sciences (WUHS), College of Pharmacy before transitioning to his current entrepreneurial role as a Psychopharmacology Consultant, Psychedelic Educator, and Founder of Spirit Pharmacist.

Ben envisions a society in which access to psychedelic drugs in a variety of safe and supported settings is available for purposes of psychospiritual well-being, personal development, ceremonial sacraments, and treatment of mental illness. His focus is on the intersection between psychiatric medications and psychedelic therapies. He has given several Continuing Education presentations to pharmacists and other healthcare professionals as well as published over a dozen articles in peer-reviewed literature relating to psychedelics or psychiatric medications.

His vision guides his clinical and education service-related professional activity.

Kelan Thomas, PharmD, MS, BCPP, BCPS will present at Psychedelic Medicine Association February 2023 member's only webinar on psychedelic drug-drug interactions

Kelan Thomas, PharmD, MS, BCPP, BCPS

Associate Clinical Professor, Touro University California

Dr. Kelan Thomas, PharmD, MS, BCPP, BCPS is an Associate Professor of Clinical Sciences at Touro University California College of Pharmacy and Board Certified Psychiatric Pharmacist with outpatient behavioral health practice sites in the San Francisco Bay Area. He has conducted clinical research related to adverse drug reactions and pharmacogenomics with the goal of optimizing pharmacotherapy for mental health clients. In 2017, he completed the California Institute of Integral Studies Certificate in Psychedelic-Assisted Therapies and Research training program, began publishing psychedelic science articles and book chapters, while also collaborating on psychedelic clinical trials at University of California, San Francisco.

Allison Feduccia, PhD Co-Founder & CEO, Psychedelic Support

Allison Feduccia, PhD

Co-Founder & CEO, Psychedelic Support

Dr. Feduccia is a neuropharmacologist who has authored 24 publications on psychedelics and mental health in peer-reviewed journals. She began researching MDMA in 2004, accumulating 17 years of experience in mental health research at UT Austin, UCSF, NIH, and MAPS. In 2018, she co-founded Project New Day, a 501(c)3 nonprofit foundation with the mission to help people overcome addiction and actualize mental health through the responsible and legal use of psychedelics. Psychedelic Support is the integration of her long-standing plant medicine practice, anchored in the belief that psychedelics can heal the soul and help us humans evolve in harmony with the earth.

As an ever-increasing number of patients begin looking into psychedelic medicines, it’s important to know when the psychedelic options that they are looking to try may interact with the pharmaceutical prescription and OTC medications they’re currently using.

For example, many patients are looking to microdose, but they may come to you asking if certain commonly microdosed substances, like LSD and psilocybin, are going to interfere with or negatively interact with their prescription medications. In addition, they may want to know which medications they’re taking may make psychedelic therapies less effective and when (and how) to safely taper those medications prior to a psychedelic medicine session.

To educate us on the drug-drug interactions between psychedelic medicines and the most common classes of medications, we are honored to welcome back two of our favorite pharmacology experts.

They’ll help elucidate:

  • The pharmacology of the most commonly used psychedelics
  • How psychedelics interact with medications like antidepressants, anti-anxiolytics, ADHD medications, etc.
  • How prescription medications may affect psychedelic journeys and effectiveness

…and much more!

As always, there will be ample time for audience Q & A, so you’ll get to interact with the panelists directly!

So please join us for this live panel discussion on Thursday, February 23rd at 5 pm Pacific, 8 pm Eastern. This is exclusively for members of the Psychedelic Medicine Association, so if you have not yet registered, please do so here. A link to the recording will be available afterward if you cannot make it to the live event.

Hope to see you all on the 23rd!

You can find the Psychedelic Medicine Association on Twitter, LinkedIn, and on Facebook.